Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

211 Views

Poster Session: Public Health

1370 - The Impact of Increased Recombinant Zoster Vaccine Use on the Burden of Herpes Zoster Among Adults Aged 50 to 59 Years

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

David Singer, PharmD, MS

Director, US Health Outcomes
GSK
Philadelphia, Pennsylvania, United States

Co-Author(s)

AS

Ahmed Salem, MSc

GSK
Wavre, Brabant Wallon, Belgium
NS

Nikita Stempniewicz, MSc

GSK
Philadelphia, Pennsylvania, United States
SM

Siyu Ma, PhD, MBBS

Tufts Medical Center
Boston, Massachusetts, United States
Sara Poston, PharmD

Head, US Health Outcomes Research, Vaccines
GSK
Philadelphia, Pennsylvania, United States
DC

Desmond Curran, PhD

GSK
Wavre, Brabant Wallon, Belgium